{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:38:54Z","timestamp":1767044334046,"version":"3.48.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,29]]},"DOI":"10.7759\/cureus.100358","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:35:56Z","timestamp":1767044156000},"source":"Crossref","is-referenced-by-count":0,"title":["Levamisole-Adulterated Cocaine: A Case of Vasculitis and Severe Neutropenia"],"prefix":"10.7759","author":[{"given":"Bartholomew","family":"Olash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.03.010","article-title":"Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge","volume":"87","author":"Lee KC","year":"2012","unstructured":"Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012, 87:581-6. 10.1016\/j.mayocp.2012.03.010","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.23907\/2017.039","article-title":"Levamisole: a high performance cutting agent","volume":"7","author":"Solomon N","year":"2017","unstructured":"Solomon N, Hayes J. Levamisole: a high performance cutting agent. Acad Forensic Pathol. 2017, 7:469-76. 10.23907\/2017.039","journal-title":"Acad Forensic Pathol"},{"key":"ref3","unstructured":"CY 2024. annual cocaine report. (2024). Accessed: September, 2025: https:\/\/www.dea.gov\/sites\/default\/files\/2025-09\/CY2024%20Annual%20Cocaine%20Report%20PRB-2025-42%20Final.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22090","article-title":"Trends of cocaine use and manifestations in hospitalized patients: a cross-sectional study","volume":"14","author":"Gangu K","year":"2022","unstructured":"Gangu K, Bobba A, Basida SD, Avula S, Chela H, Singh S. Trends of cocaine use and manifestations in hospitalized patients: a cross-sectional study. Cureus. 2022, 14:e22090. 10.7759\/cureus.22090","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0279-z","article-title":"Pathologic manifestations of levamisole-adulterated cocaine exposure","volume":"10","author":"Nolan AL","year":"2015","unstructured":"Nolan AL, Jen KY. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol. 2015, 10:48. 10.1186\/s13000-015-0279-z","journal-title":"Diagn Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-023-01358-z","article-title":"Toxic leukoencephalopathy due to suspected levamisole-adulterated cocaine","volume":"34","author":"Willems R","year":"2024","unstructured":"Willems R, You SJ, Vollmer F, Hattingen E, Weidauer S. Toxic leukoencephalopathy due to suspected levamisole-adulterated cocaine. Clin Neuroradiol. 2024, 34:503-6. 10.1007\/s00062-023-01358-z","journal-title":"Clin Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2015.3565","article-title":"Otolaryngologic manifestations of levamisole-Induced vasculitis","volume":"142","author":"Alemi AS","year":"2016","unstructured":"Alemi AS, Faden DL. Otolaryngologic manifestations of levamisole-Induced vasculitis. JAMA Otolaryngol Head Neck Surg. 2016, 142:299-300. 10.1001\/jamaoto.2015.3565","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref8","unstructured":"Levamisole. (2025). Accessed. September, 2025: https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/levamisole.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.20479","article-title":"Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis","volume":"50","author":"Wiesner O","year":"2004","unstructured":"Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, Specks U. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004, 50:2954-65. 10.1002\/art.20479","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu NY","year":"2009","unstructured":"Zhu NY, Legatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med. 2009, 150:287-9. 10.7326\/0003-4819-150-4-200902170-00102","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446245-levamisole-adulterated-cocaine-a-case-of-vasculitis-and-severe-neutropenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:35:58Z","timestamp":1767044158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446245-levamisole-adulterated-cocaine-a-case-of-vasculitis-and-severe-neutropenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.100358","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,29]]}}}